Formerly | Google Life Sciences |
---|---|
Type | Subsidiary |
Industry | |
Founded | December 7, 2015 |
Key people | Stephen Gillett (CEO) |
Revenue | US$559 million (2022) |
−US$568 million (2022) | |
Owner | Google Inc. (until 2015) Alphabet Inc. (2015–present) |
Number of employees | c. 1,100 (2023) |
Parent | Alphabet Inc. |
Subsidiaries | Lift Labs |
Website | verily |
Footnotes /references [1] |
Verily Life Sciences LLC, [2] also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. [3] [4] The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. [5] with restructuring completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily. [6] [7]
At the time of Verily's formation in 2015, the members of the research team that contributed to the founding patent portfolio include: [8]
On 9 September 2014, the division acquired Lift Labs, the makers of Liftware. [9]
Verily Life Sciences in January 2019 raised $1 billion in funding.
At the end of 2019, Verily sold its stake in robot-assisted surgery joint venture Verb Surgical to development partner Johnson & Johnson. [10]
In August 2020, Verily announced that it is entering into the insurance market with the launch of Coefficient Insurance Company. The new subsidiary will be backed by Swiss Re Group's commercial insurance unit. [11]
In September 2022, Verily announced longtime CEO Andy Conrad would step down as CEO in January 2023, to be replaced by Stephen Gillett [12] who became CEO on January 3, 2023. [13]
In January 2023, fifteen percent of Verily's workforce was laid off as part of a broader restructuring by parent company, Alphabet. [14] The Information reported in August that Gillett had told employees they would stop relying on Alphabet on "a wide range of corporate services", signaling a potential spin-out as an independent company. [15]
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.
Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the largest hospital chain in India, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries.
Google Health was a project by Google designed as an attempt to create a repository of health records and data in order to connect doctors, hospitals and pharmacies directly. The project was introduced in 2008 and discontinued in 2012. Google Health was restarted in 2018 but appeared to be discontinued in 2021 and was officially called an "effort" rather than a separate division as of 2022.
GV Management Company, L.L.C. is a venture capital investment arm of Alphabet Inc., founded by Bill Maris, that provides seed, venture, and growth stage funding to technology companies. Founded as Google Ventures in 2010, the firm has operated independently of Google, Alphabet's search and advertising division, since 2015. GV invests in startup companies in a variety of fields ranging from the Internet, software, and hardware to life science, healthcare, artificial intelligence, transportation, cyber security and agriculture. It has helped finance more than 300 companies that include Uber, Nest, Slack, and Flatiron Health.
Stephen Gillett is an American businessman, entrepreneur and technology leader. He is currently the President and chief executive officer at Verily, formerly Google Life Sciences. He was chief executive officer of Chronicle Security, an Alphabet company born out of X, the moonshot factory and founded in 2016. Gillett is also an active adviser at Google Ventures and X.
DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) who require insulin injections or pumps diabetes management. It operates internationally with headquarters in San Diego, California, has manufacturing facilities in Mesa, Arizona and Penang, Malaysia, with future manufacturing facilities in Athenry, Ireland.
Dr. Frederic Moll is a medical device developer and entrepreneur, specializing in the field of medical robotics.
X Development LLC, doing business as X, is an American semi-secret research and development facility and organization founded by Google in January 2010. X has its headquarters about a mile and a half from Alphabet's corporate headquarters, the Googleplex, in Mountain View, California.
Calico Life Sciences LLC is a subsidiary of Alphabet Inc. with a focus on biotechnology. Calico's goal is to increase the understanding of the biology that controls human aging, attempting to to devise interventions that may enable people to lead longer and healthier lives.
Google Contact Lens was a smart contact lens project announced by Google on 16 January 2014. The project aimed to assist people with diabetes by constantly measuring the glucose levels in their tears. The project was being carried out by Verily and as of 2014 was being tested using prototypes. On November 16, 2018, Verily announced it had discontinued the project.
Project Baseline is a broad effort to map human health led by Verily Life Sciences, Alphabet, Inc.'s health sciences division, and was announced in the Wall Street Journal on July 24, 2014. It begins with the ProjectBaseline Study, which will collect phenotypic health data from approximately 10,000 participants over the course of at least four years. The project employs experts from widely varying fields including science, medicine, user experience and design, engineering and patient advocacy. The project is not the first one to aim to collect data on many individuals for medical purposes, but it aims to collect a much larger amount of data covering a broader array of topics than its predecessors. De-identified Project Baseline study data will be available to qualified researchers for exploratory analysis in the future. Qualified external researchers may apply through applications reviewed by the Proposal Review and Publications Committee and Scientific Executive Committee.
Robert McKinnon Califf is an American cardiologist who currently serves as the 25th Commissioner of the Food and Drug Administration.
Alphabet Inc. is an American multinational technology conglomerate holding company headquartered in Mountain View, California. It was created through a restructuring of Google on October 2, 2015, and became the parent company of Google and several former Google subsidiaries. Alphabet is the world's third-largest technology company by revenue and one of the world's most valuable companies. It is considered one of the Big Five American information technology companies, alongside Amazon, Apple, Meta, and Microsoft.
Oscar Health, Inc. is an American health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company focuses on the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems which would make it easier for patients to navigate.
Sidewalk Labs LLC is an urban planning and infrastructure subsidiary of Google. Its stated goal is to improve urban infrastructure through technological solutions, and tackle issues such as cost of living, efficient transportation and energy usage. The company was headed by Daniel L. Doctoroff, former Deputy Mayor of New York City for economic development and former chief executive of Bloomberg L.P. until 2021. Other notable employees include Craig Nevill-Manning, co-founder of Google's New York office and inventor of Froogle, and Rohit Aggarwala, who served as chief policy officer of the company and is now Commissioner of New York City Department of Environmental Protection. It was originally part of Alphabet Inc., Google's parent company, before being absorbed into Google in 2021 following Doctoroff's departure from the company due to a suspected ALS diagnosis.
Andrew J. Conrad is an American geneticist who heads Verily, a life sciences division of Alphabet Inc. As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.
Galvani Bioelectronics is a Stevenage, United Kingdom-based bioelectronics R&D company.
A continuous glucose monitor (CGM) is a device used for monitoring blood glucose on a continual basis instead of monitoring glucose levels periodically by drawing a drop of blood from a finger. CGMs are used by people who treat their diabetes with insulin, for example people with type I diabetes, type II diabetes, or other types of diabetes, such as gestational diabetes.
Dimitri Azar is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018.
Moncef Mohamed Slaoui is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.